Artificial Intelligence and Pathology

Episode
168
Soundcloud
Share

Artificial intelligence is one of the most significant trends in most parts of society. Increasingly, oncologists and lung cancer researchers are including AI as part of their research and patient care. In this episode of Lung Cancer Considered, host Dr. Narjust Florez leads a discussion of this compelling technology, focusing on its promise and limitations.

Guest
Narjust Florez
Narjust Florez

MD

Associate Director of the Cancer Care Equity Program and Assistant Professor of Medicine
Dana-Farber Cancer Institute
Harvard Medical School
Sanja Dacic
Sanja Dacic

MD, PhD, MSc

Vice Chair and Director of Anatomic Pathology
Yale University Medical School
Fabio Ynoe de Moraes 2022 Headshot
Fabio Ynoe de Moraes

MD, PhD, MBA

Assistant Professor & Radiation Oncologist
Queen's University, Kingston Health Sciences Centre

Other Podcast

ASCO 2024 Highlights Part 2
Episode
222
ASCO 2024 Highlights Part 1
Episode
221
An Update on Lung Cancer Screening
Episode
220
LCC on World No Tobacco Day
Episode
219